$0.3950
0.0617.88%
At close: -
$0.3810
-0.01-3.54%
After Hours: May 2, 7:08 PM EDT
Comments
Loading...
Passage Bio Insider Trading Activity | NASDAQ:PASG | Benzinga
Track the latest Passage Bio insider trading activity. Stay informed on recent buys, sells, and market impact for Passage Bio stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Passage Bio Inc Insiders Doing?
At Passage Bio Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 384.63K shares worth $128.43K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On April 17, 2025, ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC, the company's 10% OWNER sold 149.05K shares for $0.33 each.
- On April 24, 2025, ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC, the company's 10% OWNER sold 235.57K shares for $0.33 each.
Ownership Statistics for Passage Bio Inc
Shares Outstanding
62.148M
Insider Shares Owned
1.934M
Insider Percentage Owned
3.11%
Institutional Shares Held
5.147M
Institutional Percentage Held
8.28%
| Apr 24, 2025 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLC | 10% OWNER | -235.57K | $0.33 | -$78.73K | SELL | -3.42% | 6.65M | Apr 22 - Apr 24 | View |
| Apr 17, 2025 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLC | 10% OWNER | -149.05K | $0.33 | -$49.70K | SELL | -2.12% | 6.89M | Apr 15 - Apr 17 | View |
| Feb 12, 2025 | Kathleen Borthwick | CFO | 4.82K | $0.53 | -$1.69K | SELL-OPTIONS | 13.21% | 41.28K | Feb 10 - Feb 11 | View |
| Jan 14, 2025 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLC | 10% OWNER | -223.22K | $0.64 | -$142.22K | SELL | -3.08% | 7.03M | Jan 10 - Jan 14 | View |
| Jan 08, 2025 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLC | 10% OWNER | -147.02K | $0.70 | -$103.31K | SELL | -1.99% | 7.26M | Jan 06 - Jan 08 | View |
| Dec 31, 2024 | Lynx Capital Management LPWeston Nichols | 10% OWNER | 373.64K | $0.65 | $241.04K | BUY | 4.21% | 9.26M | Dec 27 | View |
| Dec 26, 2024 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLC | 10% OWNER | -230.32K | $0.60 | -$138.19K | SELL | -3.02% | 7.40M | Dec 20 | View |
| Dec 11, 2024 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLC | 10% OWNER | -62.28K | $0.83 | -$51.99K | SELL | -0.81% | 7.64M | Dec 09 - Dec 11 | View |
| Dec 06, 2024 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLC | 10% OWNER | -97.10K | $0.80 | -$77.34K | SELL | -1.25% | 7.70M | Dec 04 - Dec 06 | View |
| Nov 27, 2024 | Lynx Capital Management LPWeston Nichols | 10% OWNER | 456.35K | $0.62 | $284.52K | BUY | 5.42% | 8.88M | Nov 25 - Nov 27 | View |
| Sep 23, 2024 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLC | 10% OWNER | -39.30K | $0.71 | -$27.90K | SELL | -0.50% | 7.79M | Sep 19 | View |
| Sep 18, 2024 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLC | 10% OWNER | -200.13K | $0.73 | -$146.73K | SELL | -2.49% | 7.83M | Sep 16 - Sep 18 | View |
| Feb 13, 2024 | Kathleen Borthwick | SVP, INTERIM CFO | 2.53K | $0.97 | -$1.43K | SELL-OPTIONS | 9.75% | 28.47K | Feb 10 - Feb 13 | View |
| Feb 13, 2024 | Mark Forman | CHIEF MEDICAL OFFICER | 3.36K | $0.97 | -$1.59K | SELL-OPTIONS | 7.43% | 48.63K | Feb 10 - Feb 13 | View |
| Jan 03, 2024 | Mark Forman | CHIEF MEDICAL OFFICER | 34.19K | $0.91 | -$14.39K | SELL-OPTIONS | 308.49% | 45.27K | Dec 31 - Jan 02 | View |
| Jan 03, 2024 | Kathleen Borthwick | SVP, INTERIM CFO | 19.33K | $0.91 | -$9.71K | SELL-OPTIONS | 292.49% | 25.94K | Dec 31 - Jan 02 | View |
| Jan 03, 2024 | Edgar Cale | GC & CORPORATE SECRETARY | 34.19K | $0.91 | -$14.39K | SELL-OPTIONS | 289.52% | 45.99K | Dec 31 - Jan 02 | View |
| Aug 01, 2023 | Simona King | CHIEF FINANCIAL OFFICER | 19.80K | $0.88 | -$10.08K | SELL-OPTIONS | 471.69% | 23.99K | Jul 28 | View |
| Jun 29, 2023 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLC | 10% OWNER | 1.19M | $0.84 | $1.00M | BUY | 17.43% | 8.03M | Jun 27 - Jun 28 | View |
| Jun 20, 2023 | Alexandros Fotopoulos | CHIEF TECHNICAL OFFICER | 8.45K | $0.93 | -$3.78K | SELL-OPTIONS | 41.73% | 28.69K | Jun 15 - Jun 16 | View |
| Apr 20, 2023 | Simona King | CHIEF FINANCIAL OFFICER | 4.20K | $1.05 | -$2.16K | SELL-OPTIONS | ∞ | 2.05K | Apr 18 | View |
| Dec 02, 2022 | Sandip Kapadia | DIRECTOR | -5.00K | $1.19 | -$5.96K | SELL | -100.00% | 0.00 | Dec 01 | View |
| Nov 25, 2022 | Alexandros Fotopoulos | CHIEF TECHNICAL OFFICER | 8.78K | $1.33 | -$4.95K | SELL-OPTIONS | 76.58% | 20.25K | Nov 22 | View |
| Nov 18, 2022 | Maria Monika Toernsen | CHIEF COMMERCIAL OFFICER | 3.32K | $1.51 | -$2.54K | SELL-OPTIONS | ∞ | 3.32K | Sep 15 - Sep 19 | View |
| May 05, 2022 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLC | 10% OWNER | 525.00K | $1.94 | $1.02M | BUY | 8.31% | 6.84M | May 03 - May 04 | View |
| Mar 23, 2022 | Bruce Goldsmith | CEO AND PRESIDENT | 10.00K | $3.15 | $31.50K | BUY | 167.14% | 15.98K | Mar 21 | View |
| Jan 24, 2022 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLC | 10% OWNER | 369.10K | $5.42 | $2.00M | BUY | 5.89% | 6.63M | Jan 20 | View |
| Jan 20, 2022 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLC | 10% OWNER | 168.30K | $5.38 | $905.21K | BUY | 2.76% | 6.27M | Jan 14 - Jan 19 | View |
| Jan 13, 2022 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLC | 10% OWNER | 150.00K | $5.61 | $841.08K | BUY | 2.52% | 6.10M | Jan 11 - Jan 13 | View |
| May 21, 2021 | Steven Richard Morris | CHIEF FINANCIAL OFFICER | 2.17K | $13.82 | $30.00K | BUY | 66.13% | 5.45K | May 21 | View |
| May 21, 2021 | Bruce Goldsmith | CEO AND PRESIDENT | 2.00K | $13.12 | $26.23K | BUY | 50.21% | 5.98K | May 21 | View |
| Mar 17, 2021 | Gary Romano | CHIEF MEDICAL OFFICER | 0.00 | $14.59 | -$130.31K | SELL-OPTIONS | 0.00% | 0.00 | Mar 15 | View |
| Jan 22, 2021 | Jill Quigley | CHIEF OPERATING OFFICER | -1.30K | $30.01 | -$39.01K | SELL | -0.44% | 296.28K | Jan 20 | View |
| Jan 15, 2021 | Jill Quigley | CHIEF OPERATING OFFICER | 16.30K | $30.10 | $490.57K | s | 5.79% | 297.58K | Jan 14 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
